Epilepsy and Micropakine


Epilepsy Symptoms and Causes

Epilepsy is a brain disorder that causes people to have recurring seizures. The seizures happen when clusters of nerve cells, or neurons, in the brain send out the wrong signals. People may have strange sensations and emotions or behave strangely. They may have violent muscle spasms or lose consciousness.

Epilepsy has many possible causes, including illness, brain injury, and abnormal brain development. In many cases, the cause is unknown.

Doctors use brain scans and other tests to diagnose Epilepsy. It is important to start treatment right away. There is no cure for Epilepsy, but medicines can control seizures for most people. When medicines are not working well, surgery or implanted devices such as vagus nerve stimulators may help. Special diets can help some children with Epilepsy.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for epilepsy

epilepsy treatment research studies

Micropakine clinical trials, surveys and public health registries

Find Drug Side Effect reports

Micropakine Side Effects

Epilepsy (10)
Convulsion (6)
Hallucination (3)
Pancytopenia (3)
C-reactive Protein Increased (3)
Pyrexia (3)
Systemic Inflammatory Response Syndrome (3)
Rash Morbilliform (3)
Apathy (2)
Accidental Overdose (2)
Cyanosis (2)
Overdose (2)
Fall (2)
Pancreatitis Acute (2)
Klebsiella Infection (2)
Extrapyramidal Disorder (2)
Myelodysplastic Syndrome (2)
Speech Disorder (2)
Sleep Disorder (2)
Reticulocyte Count Increased (2)
Status Epilepticus (2)
Somnolence (2)
Vomiting (2)
Treatment Noncompliance (2)
Unevaluable Event (2)
Vitamin B12 Deficiency (1)
Petit Mal Epilepsy (1)
Hepatitis Cholestatic (1)
Vessel Puncture Site Haemorrhage (1)
Overweight (1)
Throat Tightness (1)
Hepatitis Fulminant (1)
Screaming (1)
Tonsillitis (1)
Toxic Skin Eruption (1)
Urinary Incontinence (1)
Varicella (1)
Ischaemic Stroke (1)
Mental Disorder (1)
Mouth Ulceration (1)
Menstruation Irregular (1)
Menstrual Disorder (1)
Menometrorrhagia (1)
Oppositional Defiant Disorder (1)
Liver Disorder (1)
Incoherent (1)
Inflammation (1)
Intestinal Obstruction (1)
Lipase Increased (1)
Hyperammonaemia (1)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

And ive had 6 or 7 seizures and i also think ive had a couple in my sleep :(

I took my Epilepsy's medicine twice cuz i forgot that i took it the first time .. is that bad ?? is it gonna effect me in any way ? please answer my Question!

I was only in 5th grade when i had my first seizure. Ive only had three seizure so far im only 13 years old right now im in 8th grade when i grow up i want to be in the military or police force. Myfamily has told me that i probably won't be

Why do i feel depressed all the time is it because i have eplilepsy but im only 13 years o old

is epilepsy is life long?????

66 yearr old male living in Winnipeg, MB Cannada. Ialso have other medical problems besides this one. Like Epilepsy, Antidepressant,Migraines,Chloresterol,Klinefelter's Syndrome,High blood pressure, Shortness of breath, HIV, ITCHING.

Alternative to Lofepramine, bearing in mind that patient has epilepsy

Docetaxel and Lamictal cause vertigo after first Lamictal pill in a.m., even tho I'm a couple of weeks since last infusion. Taxotere for advanced prostate cancer; Lamictal for epilepsy. Neurologist doesn't want to lower Lamictal dose; I'm on a trial

Epilum - I have been treated for epilepsy from the age of 14, I am now 34. I have had only 3 episodes in my life. I have used convulex which worked very well. Dr switched me to rivitrol when I wanted to get pregnant.&

G'day all. Have tried other products, have seen epilepsy induced by another quitting drug in a patient taking Sodium Valproate as mood stabilizer. Wondering if any reactions like this have been observed. Also, any info on reactions with Seroquel or o

Hi my Mom is 78yo and had her first seizure 5mths ago (we think due to the flu vaccine)and another 4wks ago, she was diagnosed with Epilepsy after her second episodeand put on Epilim. Since then she has deteriorated sign

Hi, I was diagnosed with Epilepsy about 2 months ago after small misdiagnosed seizures evolved into 'Grand Mal' seizures. I have been taking 300mg Epanutin per day (3x100mg capsules), and so far have had no further seizures, small or large. My

I am new to taking medicine for epilepsy, but i have had all of my life, but i can tell you that keppra was the worst medicine. I cried all the time, suicidal, and anxious. but icame completely off of keppra and swithched to lamictal alone and i stil

I am now 37 and have been on epilim for the past 19 years. I stuggle alot with my weight and have even considered a gastric bypass but after doing some research found out that people who suffered from epilepsy who had the operatin only got worse so d

Epilepsy Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
Condition: Epilepsy
Interventions: Drug: Divalproex Sodium Extended-release 250mg;   Drug: DEPAKOTE 250mg
Outcome Measure: Evaluate generic divalproex sodium extended release to Depakote ER
2 Recruiting Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex
Conditions: TSC;   Tuberous Sclerosis Complex;   Epilepsy
Intervention: Device: Epilepsy early diagnosis protocol
Outcome Measure: number of patients with Epilepsy
3 Unknown  Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services
Condition: Medically Intractable Epilepsy
Interventions: Behavioral: Andrews/Reiter approach to Epilepsy;   Behavioral: Relaxation/Meditation
Outcome Measures: Fraction of seizure free study subjects;   Fraction of subjects achieving a clinically meaningful reduction of seizure frequency;   Subjective Handicap of Epilepsy;   Health-related self-efficacy;   Psychopathologic disorders and stress;   Quality of life
4 Unknown  The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
Condition: Intractable Epilepsy
Interventions: Other: Reduction of anti-epileptic medications;   Procedure: No drug change
Outcome Measures: Effect of reduction in anti-epileptic medications on quality of life in young people with intractable Epilepsy;   Identify other determinants of quality of life in this group of subjects
5 Recruiting Policy on Optimal Epilepsy Management
Conditions: Epilepsy;   Seizure Disorder
Intervention: Behavioral:
Outcome Measures: Epilepsy Self-Management;   Epilepsy Self-Efficacy;   Epilepsy Self-Management Information Scale
6 Recruiting The Human Epilepsy Project
Condition: Focal Epilepsy
Outcome Measure: Presence of Biomarker(s) Predictive of Anti-epileptic Drug Treatment Response
7 Recruiting Genetics of Severe Early Onset Epilepsies
Conditions: Epilepsy;   Epileptic Encephalopathy;   Ohtahara Syndrome;   Infantile Spasms;   Dravet Syndrome;   Malignant Migrating Partial Epilepsy of Infancy;   Early Myoclonic Epileptic Encephalopathy
Outcome Measure: Identify new or existing causative mutations through whole exome sequencing of Epilepsy patients
8 Recruiting Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
Condition: Epileptic Seizures
Outcome Measures: A two-year incidence rate of new-onset seizures and/or newly-diagnosed Epilepsy among seniors in southeastern Arizona.;   Compare the impact of Epilepsy on the different ethnic groups of seniors with Epilepsy
9 Recruiting Surgery as a Treatment for Medically Intractable Epilepsy
Conditions: Epilepsy;   Epilepsy, Temporal Lobe;   Partial Epilepsy
Intervention: Procedure: Surgery
Outcome Measures: Change in seizure frequency, as measured by the Engel scale before and one year after treatment;   Percentage seizure-free;   Mean Engel Class one year after surgery;   Percentage with permanent neurological side-effects from surgical treatment;   Incidence of serious complications of epileptic seizures
10 Recruiting Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
Condition: Epilepsy
Intervention: Other: ketogenic diet
Outcome Measures: Change from baseline in epileptic seizure frequency.;   Evaluate the number of participants with adverse events.
11 Recruiting Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy
Conditions: Partial Epilepsy;   Surgery
Interventions: Procedure: AN-DBS;   Drug: Usual treatment
Outcome Measures: Assessment of effectiveness of thalamic DBS on seizures severity;   Cost-utility analysis from the perspective of Medicare;   Comparison of the improvement of quality of life and overall neuropsychological impact;   Comparison the adverse effects (including depression);   Impact of th new therapeutic strategy on the hospital budget
12 Recruiting Epilepsy-Associated Stigma
Condition: Epilepsy
Outcome Measures: score of perceived stigma;   Evaluation of the illness experience will be performed by the first section of the EMIC.;   Evaluation of the representations of Epilepsy (perceived causes) will be done by the second section of the EMIC
13 Recruiting Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Conditions: Childhood Absence Epilepsy;   Epilepsy;   Seizures
Outcome Measure: Saliva sample
14 Recruiting Epilepsy Birth Control Registry
Condition: Epilepsy
Intervention: Other: Non-interventional
Outcome Measure: Number of seizures on hormonal versus non-hormonal contraception, stratified by antiepileptic drug category
15 Unknown  Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy
Conditions: Epilepsy;   Epilepsia;   Epileptic Seizures;   Seizure Disorder
Intervention: Behavioral: Physical activity
Outcome Measures: Cognitive function (concentration and attention);   physical fitness;   Brain-derived neurotrophic factor (BDNF);   Bone mineral density;   Thyroidea Stimulating Hormone (TSH);   Insulin;   Glucose;   Lipids;   C-reactive-protein;   Seizure frequency;   Blood pressure
16 Recruiting Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
Conditions: Epilepsy;   Focal Epilepsy;   Generalized Epilepsy
Intervention: Other: Modified Atkins diet treatment
Outcome Measures: Change in seizure frequency;   Change in body weight;   Change in standard 3-hrs EEG;   Change in life quality measured by validated questionnaire;   Change in various blood and serum measures;   Change in executive functions measured with validated questionnaire;   Change in seizure strength and severity measured by validated questionnaire
17 Unknown  Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
Conditions: Epilepsy;   Glioma
Outcome Measures: to correlate the efficacy of post-operative levetiracetam monotherapy in newly diagnosed glioma patients suffering from Epilepsy with expression of synaptic vesicle protein 2A (SV2A).;   to determine the impact of levetiracetam monotherapy on neurocognitive functioning, health-related quality of life, and epileptic brain activity as measured by MEG, in newly diagnosed glioma patients with Epilepsy
18 Recruiting PRX-00023 Therapy in Localization-Related Epilepsy
Conditions: Epilepsy;   Epilepsy, Temporal Lobe;   Partial Epilepsy
Intervention: Drug: PRX-00023
Outcome Measures: Seizure frequency counts during the 3 month placebo and active treatment phases;   Proportion of patients with greater than or equal to 50% lower seizure rate on PRX-0023 than placebo;   Safety assessment for adverse events, changes in vital signs, laboratory test results and physical examination.;   Hamilton Depression and Anxiety rating scales;   Performance on neuropsychological testing scales;   Columbia suicide severity rating scale
19 Recruiting Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)
Conditions: Epilepsy;   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Depression
Intervention: Behavioral: TIME
Outcome Measures: Change in Montgomery Asberg Depression Rating Scale (MADRS);   Epilepsy Self-Efficacy Scale (ESES);   Rapid Estimate of Adult Literacy in Medicine, Revised (REALM-R);   Multidimensional Scale of Perceived Social Support (MSPSS);   Internalized Stigma of Mental Illness (ISMI);   Stigma Scale of Epilepsy (SSE);   Health-Related Quality of Life;   Tablet Routines Questionnaire (TRQ);   World Health Organization Disability Assessment (WHODAS II);   Quality of Life Questionnaire (QOLIE-10);   Neurology Quality of Life measures (Neuro-QOL);   Patient Health Questionnaire (PHQ-9);   Addiction Severity Index (ASI) Drug Alcohol Use;   Pittsburgh Sleep Quality Index (PSQI);   Brief Psychiatric Rating Scale (BPRS);   Global Assessment of Functioning (GAF);   Clinic Visit Adherence;   Adverse Events/ER Visits;   Seizure Diary
20 Recruiting Cardiac Arrhythmias in Epilepsy: the CARELINK-study
Conditions: Epilepsy;   Asystole;   Cardiac Arrhythmias
Intervention: Device: implantable heart rate monitor
Outcome Measures: Incidence and two-year prevalence of clinically relevant cardiac arrhythmia.;   the number of patients who will have received a permanent pacemaker at the end of this study.